Ceftiofur

Verify with FDA CVM →

536 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
536
Total Reports
197
Deaths Reported
3680.0%
Death Rate

Active Ingredients

Ceftiofur

Administration Routes

IntramuscularUnknownSubcutaneousIntravenousParenteralIntra-ArterialOralSubconjunctivalIntradermalOphthalmic

Species Affected

Cattle 223
Horse 198
Unknown 65
Human 23
Pig 14
Dog 8
Goat 3
Cat 2

Most Affected Breeds

Cattle (unknown) 96
Unknown 88
Quarter Horse 56
Horse (unknown) 41
Thoroughbred 41
Crossbred Bovine/Cattle 36
Cattle (other) 35
Holstein-Friesian also known as Holstein 34
Horse (other) 14
Aberdeen Angus 11

Most Reported Reactions

Injection site swelling 134
Lack of efficacy (bacteria) - NOS 114
Death 94
Injection site pain 63
Unclassifiable adverse event 52
DEATH-TREATMENT FAILURE 47
Fever 39
Injection site inflammation 33
Depression 29
Diarrhoea 28
Death by euthanasia 27
Lack of efficacy - NOS 27

Outcome Breakdown

Died
192 (68.6%)
Outcome Unknown
40 (14.3%)
Recovered/Normal
22 (7.9%)
Ongoing
13 (4.6%)
Euthanized
13 (4.6%)

Data Summary

Metric Value
Total adverse event reports 536
Reports involving death 197
Case-fatality rate (reported events) 3680.0%
Distinct species in reports 8
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ceftiofur Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 536 adverse event reports referencing Ceftiofur, including 197 reports in which the animal died — a 3680.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ceftiofur. Reported administration routes include Intramuscular, Unknown, Subcutaneous, Intravenous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ceftiofur reports are Cattle (223 reports), Horse (198 reports), Unknown (65 reports), with Cattle accounting for the largest share. Within those species, Cattle (unknown) (96), Unknown (88), Quarter Horse (56) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ceftiofur are Injection site swelling (134), Lack of efficacy (bacteria) - NOS (114), Death (94), Injection site pain (63). Of the 280 reports with a coded outcome, Died is the leading category at 68.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ceftiofur.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial